Lupus UK Treatment

lupus uk treatmentLupus UK Treatment:

Our Lupus UK treatment focuses on the underlying issues and  not just the symptoms.

Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body’s immune system mistakenly attacks healthy tissue in many parts of the body, including the organs such as the kidneys, lungs, heart, brain etc.

Symptoms may be mild to severe. Common symptoms include painful , swollen painful joints; fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, fatigue and a red rash which is most commonly on the face. There are often flares and periods of remission, when there are few symptoms. Lupus is Latin for wolf as in the 18th century it was thought to be caused by a wolf’s bite.

The cause is not entirely clear according to mainstream medicine. It is believed to involve hormonal, environmental, and genetic factors. The mechanism involves an immune response by autoantibodies against a person’s own tissues. These are most commonly anti-nuclear antibodies and they result in inflammation. There are a number of other kinds of lupus erythematosus including discoid lupus erythematosus, subacute cutaneous lupus erythematosus and neonatal lupus. Patients of orthodox medicine are usually told there is no cure for SLE. Pharmaceutical treatments may include NSAIDs, corticosteroids, immunosuppressants, hydroxychloroquine, and methotrexate – a chemotherapy drug.

Women of childbearing age are affected about nine times more often than men. While it most commonly begins between the ages of 15 and 45 a wide range of ages can be affected. SLE is one of several diseases known as “the great imitators” because it often mimics or is mistaken for other illnesses.

Using functional medicine tests, our aim in Lupus UK treatment is to diagnose and address the underlying issues that are fuelling the condition. It is indeed a multi-faceted condition and in our experience usually has several drivers. A treatment plan using non pharmaceeutical medicine is then formulated, based on the test results and to meet each patient’s unique needs. We do not have a one size fits all approach.

We also address any gut issues, which are often associated with this condition.

Poster courtesy of Lupus UK


Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Wang M, Gladman DD, Ibañez D, Urowitz MB.Arthritis Care Res (Hoboken). 2012 Jun;64(6):833-7. doi: 10.1002/acr.21624. Epub 2012 Jan 30.PMID: 22290935
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT; Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.Ann Rheum Dis. 2008 Feb;67(2):195-205. doi: 10.1136/ard.2007.070367. Epub 2007 May 15.PMID: 17504841
Systemic lupus erythematosus: a case-based presentation of renal, neurologic, and hematologic emergencies. Campbell EJ, Clarke AE, Ramsey-Goldman R.Expert Rev Clin Immunol. 2018 Oct;14(10):803-816. doi: 10.1080/1744666X.2018.1518132. Epub 2018 Sep 20.PMID: 30173578 Review.
[Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus]. Lefèvre G, Zéphir H, Warembourg F, Michelin E, Pruvo JP, Hachulla E, Semah F, Dubucquoi S, Lenfant P, Vermersch P, Hatron PY, Prin L, Launay D.Rev Med Interne. 2012 Sep;33(9):491-502. doi: 10.1016/j.revmed.2012.03.356. Epub 2012 May 11.PMID: 22579860 Review.

If you would like this approach to Lupus UK treatment

Contact Deborah’s Medical Secretary for an appointment